NKI, an early adopter of digital pathology, selected the enterprise-grade Concentriq Dx* to serve as the modern platform at the center of its growing oncology practice.
*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency.
Featured Story:
Latest Articles
March 5, 2024
February 27, 2024